MYO

Myomo, Inc. (MYO) ESG Analysis Analysis (2026)

Invetso Score: 6.5/10 — Balanced · Last Updated: 2026-09-01

Environmental

MYO's R&D intensity at 15.0% of revenue suggests a relatively science-led operating model, but peers with similar medtech profiles often show comparable innovation burdens.

Negative net debt to EBITDA indicates limited balance-sheet pressure, which can support environmental investment flexibility versus more leveraged peers, though this is not an environmental advantage itself.

The provided metrics do not show direct emissions, energy, or waste disclosures, leaving MYO's environmental positioning harder to verify than peers with fuller sustainability reporting.

Absent evidence of material environmental liabilities or high resource intensity, MYO appears broadly neutral versus peers on near-term environmental risk exposure.

Social

High R&D spending relative to revenue can support product performance and patient outcomes, which is a material social strength versus peers with lower innovation intensity.

Stock-based compensation at 2.7% of revenue suggests moderate dilution pressure, but it is not unusually high versus growth-oriented healthcare peers.

The available metrics do not indicate labor, safety, or supply-chain controversies, so MYO appears cleaner than peers facing recurring social incidents.

Because the business appears innovation-driven and healthcare-adjacent, its social profile is stronger than average peers where product quality and patient trust are central.

Governance

Debt-to-equity of 3.44 points to a more leveraged capital structure than many peers, which can constrain governance flexibility and heighten oversight demands.

Stock-based compensation at 2.7% of revenue is manageable, but it still creates dilution risk that peers with tighter compensation discipline may avoid.

The absence of board, audit, and ownership data limits confidence in governance quality, leaving MYO below peers with clearer disclosure and control frameworks.

Negative net debt to EBITDA partially offsets leverage concerns, but the overall governance profile remains only average because structural oversight metrics are not provided.

Overall Score

MYO's ESG profile is mixed, with stronger social positioning from innovation intensity, but only moderate environmental and governance visibility versus peers.

Score Driver: Innovation-Led Social Strength Is Offset By Limited Disclosure And A Leveraged Capital Structure.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Myomo, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →